News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 449
- Sources here
- 19
- Companies here
- 17
Search results
Stored financial headlines
Active search
449 matching headlines
Ticker or company: LTEMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
PRNAF SEC Filings - ALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for ALTERITY THERAPEUTICS LTD (PRNAF) SEC filings, including annual 10-K reports, quarterly 10-Q reports, 8-K material events, and insider trading forms. It highlights the company's focus on neurodegenerative diseases and offers details on recent filings, AI-generated summaries, impact …
ATHE
main company
Sharemaestro market context
Trend signal active
52 weeks -4.6% · Next-week setup negative 40.1%
Natural Alternatives International, Inc. Revenue Breakdown – NASDAQ:NAII
This article provides a revenue breakdown for Natural Alternatives International, Inc. (NASDAQ: NAII). The primary contributor to the company's revenue is the United States, which generated $79.13 million USD last year, an increase from $73.51 million USD in the prior year. The data presented …
NAII
main company
Sharemaestro market context
Price below Trend Line
52 weeks -48.7% · Next-week setup negative 41.2%
PulteGroup (PHM) Stock Still Looks Cheap On Mixed Housing Demand News
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. PulteGroup stock has delivered a strong 150.5% total return over the past five years, yet current valuation checks suggest the market price may …
PHM
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
PHM or NVR: Which Is the Better Value Stock Right Now?
Investors interested in Building Products - Home Builders stocks are likely familiar with PulteGroup (PHM) and NVR (NVR). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. We have found that the best …
Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup negative 36.7%Eltek Ltd Today's Market Trends | ELTK Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey
This article provides an overview of Eltek Ltd (ELTK) stock, highlighting its current market trends, key figures, and fundamental analysis. It notes that Eltek's fundamentals are relatively healthy with good growth potential, and the stock is considered fairly valued. The company manufactures custom-made printed …
ELTK
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.6%
Eltek Ltd (ELTK) Financial Health: Profitability & Balance Sheet Analysis
This article analyzes Eltek Ltd's (ELTK) financial health, ranking it 88 out of 105 in the Semiconductors & Semiconductor Equipment industry with a stable financial status and average operating efficiency. The company's latest quarterly revenue decreased by 18.19% year-over-year, and net profit experienced a …
ELTK
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.6%
ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Releases Appendix 4C - Q4 FY26 Quarterly Cash Flow Report & Corporate Update
Alterity Therapeutics released its Q4 FY26 Quarterly Cash Flow Report and corporate update, highlighting a positive End-of-Phase 2 meeting with the FDA, which confirmed a registrational pathway for ATH434 in Multiple System Atrophy (MSA) with a single pivotal Phase 3 trial plus confirmatory evidence. …
ATHE
main company
Sharemaestro market context
Trend signal active
52 weeks -4.6% · Next-week setup negative 40.1%
Eltek Ltd (ELTK) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Eltek Ltd (ELTK), detailing its volatility, financial risk, and investment risk. Eltek Ltd has a risk assessment score of 2.77, ranking 84 out of 105 in the Semiconductors & Semiconductor Equipment industry, and a beta of 0.76, …
ELTK
main company
Sharemaestro market context
Price below Trend Line
52 weeks -14.6%
Natural Alternatives International Inc (NAII) Valuation: PE, PB & Fair Value Analysis
The article provides a valuation analysis for Natural Alternatives International Inc (NAII), noting its current valuation score of 8.17, which ranks it 100 out of 155 in the Pharmaceuticals industry. It highlights the company's current P/E ratio of -1.01, indicating a significant drop from …
NAII
main company
Sharemaestro market context
Price below Trend Line
52 weeks -48.7% · Next-week setup negative 41.2%
PulteGroup (PHM) Could Be 31% Undervalued After Softer Q2 Earnings
PulteGroup (PHM) saw its stock in focus after reporting softer Q2 2026 earnings, with lower revenue and net income. Despite this, the company is considered undervalued by 30.5%, with a fair value of $190.45 per share against its current price of $132.31, largely due …
PHM
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
PulteGroup Inc. stock underperforms Thursday when compared to competitors
PulteGroup Inc. (PHM) stock fell 2.70% on Thursday, closing at $128.74, while the broader market saw gains. The S&P 500 Index rose 1.66% and the Dow Jones Industrial Average increased by 1.19%. This marks the second consecutive day of losses for PulteGroup.
PHM
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
PHM Company (NYSE: PHM) files Form 144 for 1,165,000-share stock sale
PulteGroup Inc./MI (NYSE: PHM) has filed a Form 144, indicating a planned sale of up to 1,165,000 common shares through Raymond James & Associates on the NYSE. As of August 5, 2026, the company has 187,452,540 common shares outstanding. The filing also details recent …
PHM
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
This Top Homebuilder's CEO Just Said the Housing Market Is 'Pretty Good'— Even as Revenue Fell 11%
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. PulteGroup, Inc. CEO Ryan Marshall said that the U.S. housing market remains stronger than many believe, pointing to broad-based demand across buyer segments and continued momentum in …
Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup negative 36.7%Alterity Therapeutics Q4 Results: FDA aligns on ATH434 Phase 3
Alterity Therapeutics announced that the FDA has agreed to a single pivotal Phase 3 trial for its lead asset, ATH434, in Multiple System Atrophy, clearing a significant regulatory hurdle. The company reported A$37.3 million in cash as of June 30, 2026, and received an …
ATHE
main company
Sharemaestro market context
Trend signal active
52 weeks -4.6% · Next-week setup negative 40.1%
Wolters Kluwer to Help Rural Hospitals and FQHCs Access Top Drug Information and Patient Education Solutions Integrated With Epic
Epic customers can opt for turnkey access to UpToDate Lexidrug, Medi-Span and UpToDate Patient Education solutions WALTHAM, Mass., July 30, 2026--(BUSINESS WIRE)--Wolters Kluwer Health is working with Epic to offer an integrated set of clinical content solutions, UpToDate Lexidrug®, Medi-Span®, and UpToDate Patient Education, …
Sharemaestro market context Price above Trend Line 52 weeks -37.4% · Next-week setup negative 42.8%Alterity’s ATH434 Trial for Rare MSA May Enroll 200 Patients
Alterity Therapeutics announced that the FDA has aligned on a registrational pathway for its drug ATH434 for Multiple System Atrophy (MSA), requiring a single pivotal Phase 3 trial and confirmatory evidence from its Phase 2 study. The planned Phase 3 trial will enroll approximately …
Sharemaestro market context Trend signal active 52 weeks -9.2% · Next-week setup negative 26.5%Alterity Therapeutics (NASDAQ: ATHE) outlines FDA-backed Phase 3 plan for ATH434
Alterity Therapeutics announced securing FDA alignment for a registrational pathway for its ATH434 drug in Multiple System Atrophy (MSA). The FDA agreed that a single pivotal Phase 3 trial, supported by confirmatory evidence from an ongoing Phase 2 study, could suffice for New Drug …
ATHE
main company
Sharemaestro market context
Trend signal active
52 weeks -4.6% · Next-week setup negative 40.1%
Share Buyback Transaction Details July 23 – July 29, 2026
PRESS RELEASE Share Buyback Transaction Details July 23 – July 29, 2026 Alphen aan den Rijn – July 30, 2026 - Wolters Kluwer (Euronext: WKL), aglobal leader in professional information solutions, software and services, today reports that it has repurchased 57,260 of its own …
Sharemaestro market context Price above Trend Line 52 weeks -37.4% · Next-week setup negative 42.8%Natural Alternatives International Inc (NAII) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Natural Alternatives International Inc (NAII), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. According to TradingKey, NAII's stock is currently suitable for range-bound swing trading with …
NAII
main company
Sharemaestro market context
Price below Trend Line
52 weeks -48.7% · Next-week setup negative 41.2%